hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

Oncogene

Volumn 15, Issue 1, 1997, Pages 45-52

  Brown, Robert ^a   Hirst, Gillian L ^a   Gallagher, William M ^a   McIlwrath, Amanda J ^a   Margison, Geoffrey P ^b   Van Der Zee, Ate G J ^c   Anthoney, D Alan ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cisplatin; Drug resistance; Mismatch repair; Ovarian cancer

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; CISPLATIN; DOXORUBICIN; METHYLNITROSOUREA; PROTEIN SUBUNIT; TIOGUANINE;

ARTICLE; BASE MISPAIRING; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; DRUG RESISTANCE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 0030741503     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201167     Document Type: Article

References (41)

1. Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland CR, Koi M, Fishel R and Howell SB. (1996). Cancer Res., 56, 3087-3090.
2. Anthoney DA, McIlwrath AJ, Gallagher WM, Edlin ARM and Brown R. (1996). Cancer Res., 56, 1374-1381.
3. Aquilina G, Giammarioli AM, Zijno A, DiMuccio A, Doglioti E and Bignami M. (1990). Cancer Res., 50, 4248-4253.
4. Beranek DT. (1990). Mutation Res., 231, 11-30.
5. Brown R, Clugston C, Burns P, Edlin A, Vasey P, Vojtesek B and Kaye SB. (1993). Int. J. Cancer, 55, 678-684.
6. Bubb VJ, Curtis LJ, Cunningham C, Dunlop MG, Carothers AD, Morris RG, White S, Bird CC and Wyllie AH. (1996). Oncogene 12, 2641-2649.
7. Chambers SR, Hunter N, Louis EJ and Boris RH. (1996). Mol. Cell. Biol., 16, 6110-6120.
8. Dolan ME, Stine L, Mitchell RB, Moschel RC and Pegg AE. (1990). Cancer Communications, 2, 371-377.
9. Drummond JT, Anthoney A, Brown R and Modrich P. (1996). J. Biol. Chem., 271, 19645-19648.
10. Duckett DR, Drummond JT, Murchie AIH, Reardon JT, Sancar A, Lilley DM and Modrich P. (1996). Proc. Natl. Acad. Sci. USA, 93, 6443-6447.
11. Eastman A. (1990). Cancer Cells, 2, 275-280.
12. Edelmann W, Cohen PE, Kane M, Lau K, Morrow B, Bennett S, Ulmar A, Kunkel T, Cattoretti G, Chagnati R, Pollard JW, Kolodner RD and Kucherlapati R. (1996). Cell, 85, 1125-1134.
13. Evans DL, Tilby M and Dive C. (1994). Cancer Res., 54, 1596-1603.
14. Fichtinger-Schepman AM, van der Veer JL, Den Hartog JH, Lohman PHM and Reedijk J. (1985). Biochemistry, 24, 707-713.
15. Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehme A, Christen RD and Howell SB. (1996). Cancer Res., 56, 4881-4886.
16. Fujita M, Enomoto T, Yoshino K, Nomura T, Buzard GS and Inoue M. (1995). Int. J. Cancer, 64, 361-366.
17. Gallagher WM, Cairney M, Scott B, Roninson IB and Brown R. (1997). Oncogene, 14, 185-193.
18. Hawn MT, Umar A, Carethers JM, Marra G, Kunkel TA, Boland CR and Koi M. (1995). Cancer Res., 55, 3721-3725.
19. Hoffmann J, Pillaire M, Maga G, Podust V, Hubscher U and Villani G. (1995). Proc. Natl. Acad. Sci. USA, 92, 5356-5360.
20. Hoffmann J, Pillaire M, Lesca C, Burnoug D, Fuchs RPP, Defais M and Villani G. (1996). Proc. Natl. Acad. Sci. USA, 93, 13766-13769.
21. Karran P and Bignami M. (1994). BioEssays, 16, 833-839.
22. Kaye SB. (1996). Annal. Oncol., 7, 9-13.
23. King BL, Carcangiu ML, Carter D, Kiechle M, Pfisterer J, Pfleiderer A and Kacinski BM. (1995). Br. J. Cancer, 72, 376-382.
24. Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA and Boland CR. (1994). Cancer Res., 54, 4308-4312.
25. Mamenta EL, Poma EE, Kaufmann WK, Delmastro DA, Grady HL and Chaney SG. (1994). Cancer Res., 54, 3500-3505.
26. Mello JA, Acharya S, Fishel R and Essigmann JM. (1996). Chem. Biol., 3, 579-589.
27. Moggs JG, Yarema KJ, Essigmann JM and Wood RD. (1996). J. Biol. Chem., 271, 7177-7186.
28. Morten JEN and Margison GP. (1988). Carcinogenesis, 9, 45 49.
29. Murphy DS, Hoare SF, Going JJ, Mallan EEA, George WD, Kaye SB, Brown R, Black DM and Keith WN. (1995). J. Natl. Cancer Inst., 87, 1694-1704.
30. Ormerod MG, O'Neill CF, Robertson D and Harrap KR. (1994). Exp. Cell Res., 211(2), 231 237.
31. Papadopoulos N, Nicolaides NC, Wei Y, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomaki P, Mecklin J, de la Chapelle A, Kinzler KW and Vogclstein B. (1994). Science, 263, 1625-1628.
32. Paulson TG, Wright FA, Parker BA, Russack V and Wahl GM. (1996). Cancer Res., 56, 4021-4026.
33. Reed E, Kohn EC, Sarosy G, Dabholkar M, Davis P, Jacob J and Maher M. (1995). Sem. Oncol., 22, 90-96.
34. Sorenson CM, Barry MA and Eastman A. (1990). J. Natl. Cancer Inst., 82, 749-755.
35. Szymkowski DE, Yarema K, Essigmann JM, Lippard SJ and Wood RD. (1992). Proc. Natl. Acad. Sci. USA, 89, 10772-10776.
36. Umar A, Boyer JC, Thomas DC, Nguyen DC, Risinger JI, Boyd J, Ionov Y, Perucho M and Kunkel TA. (1994). J. Biol. Chem., 269, 14367 14370.
37. Van der Zee AGJ, De Vries EGE, Hollema H, Kaye SB, Brown R and Keith WN. (1994). Annals of Oncology, 5, 75-81.
38. van der Zee AG, Hollema H, Suurmeijer AJ, Krans M, Sluiter WJ, Aalders JG and de Vries EG. (1995). J. Clin. Oncol., 13, 70 78.
39. Vojtesek B, Bartek J, Midgley CA and Lane DP. (1992). J. Immunol. Meth., 151, 237-244.
40. Yamada M, O'Regan E, Brown R and Karran P. (1997). Nucl. Acids Res., 25, 491-495.
41. Zamble DB and Lippard SJ. (1995). TIBS, 20, 435-439.